Relation Therapeutics

Series BBiotechnologyprivate

Machine learning-driven drug discovery company mapping human disease biology at single-cell resolution.

Valuation
$300M
Total Funding
$50M
Stage
Series B
Sector
Biotechnology
Headquarters
London, UK
CEO
Mark Kotter
IPO Status
private

Funding History

Round Amount Date
Series B $50M Jun 2022
Seed $10M Mar 2021

Track Relation Therapeutics IPO timeline, funding rounds, investor activity, and valuation on TechStackIPO โ€” the pre-IPO intelligence platform.

Loading company data...